{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:31:53Z","timestamp":1784158313621,"version":"3.55.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.00330","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T04:30:41Z","timestamp":1596601841000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Quality of Life, Anxiety, and Depression in Patients With Early-Stage Mycosis Fungoides and the Effect of Oral Psoralen Plus UV-A (PUVA) Photochemotherapy on it"],"prefix":"10.3389","volume":"7","author":[{"given":"Thomas","family":"Graier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Fink-Puches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Porkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"P\u00f6chlauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Ratzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Tanew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Selhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul-Gunther","family":"Sator","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gruber-Wackernagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz J.","family":"Legat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Augusto","family":"Vieyra-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Quehenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/cncr.22252","article-title":"Significant impact of cutaneous T-cell lymphoma on patients' quality of life: results of a 2005 National cutaneous lymphoma foundation survey","volume":"107","author":"Demierre","year":"2006","journal-title":"Cancer."},{"key":"B2","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/bjd.18089","article-title":"Characteristics associated with significantly worse quality of life in mycosis fungoides\/S\u00e9zary syndrome from the prospective cutaneous lymphoma International prognostic index (PROCLIPI) study","volume":"182","author":"Molloy","year":"2019","journal-title":"Br J Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2340\/00015555-1496","article-title":"New insights into associated co-morbidities in patients with cutaneous T-cell lymphoma (mycosis fungoides)","volume":"93","author":"Hodak","year":"2013","journal-title":"Acta Derm Venereol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1365-2133.2008.08992.x","article-title":"Quality of life and psychological distress in patients with cutaneous lymphoma","volume":"160","author":"Sampogna","year":"2009","journal-title":"Br J Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jdv.16021","article-title":"Clinical severity measures and quality of life burden in patients with mycosis fungoides and S\u00e9zary syndrome: comparison of generic and dermatology-specific instruments","volume":"34","author":"Herbosa","year":"2019","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/bjd.17941","article-title":"Health-related quality of life and economic implications of cutaneous T-cell lymphoma","volume":"182","author":"Semenov","year":"2019","journal-title":"Br J Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2340\/00015555-3171","article-title":"Health-related quality of life in cutaneous lymphomas: past, present and future","volume":"99","author":"Jonak","year":"2019","journal-title":"Acta Derm Venereol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jid.2019.07.712","article-title":"Overall survival in mycosis fungoides: a systematic review and meta-analysis","volume":"140","author":"Mourad","year":"2020","journal-title":"J Invest Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"223.e1","DOI":"10.1016\/j.jaad.2013.08.033","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome): part II prognosis, management, and future directions","volume":"70","author":"Jawed","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","article-title":"European organisation for research and treatment of cancer consensus recommendations for the treatment of mycosis fungoides\/Sezary syndrome - update 2017","volume":"77","author":"Trautinger","year":"2017","journal-title":"Eur J Cancer."},{"key":"B11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(17)31266-7","article-title":"Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial","volume":"390","author":"Prince","year":"2017","journal-title":"Lancet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3816\/CLM.2002.n.003","article-title":"Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK)","volume":"2","author":"Duvic","year":"2002","journal-title":"Clin Lymphoma."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1038\/bjc.2013.616","article-title":"Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma","volume":"109","author":"Illidge","year":"2013","journal-title":"Br J Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.clml.2011.03.003","article-title":"Multicenter photopheresis intervention trial in early-stage mycosis fungoides","volume":"11","author":"Talpur","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1002\/cncr.27627","article-title":"Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian group of cutaneous lymphomas","volume":"118","author":"Quaglino","year":"2012","journal-title":"Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bjd.14317","article-title":"British association of Dermatologists and British photodermatology group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015","volume":"174","author":"Ling","year":"2016","journal-title":"Br J Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1468-3083.2012.04520.x","article-title":"Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review","volume":"26","author":"Gallini","year":"2012","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1067\/mjd.2001.114576","article-title":"The risk of melanoma in association with long-term exposure to PUVA","volume":"44","author":"Stern","year":"2001","journal-title":"J Am Acad Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1056\/NEJM199704103361501","article-title":"Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet a radiation (PUVA)","volume":"336","author":"Stern","year":"1997","journal-title":"N Engl J Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1001\/jamadermatol.2018.5905","article-title":"Evaluation of low-dose, low-frequency oral Psoralen-UV-A treatment with or without maintenance on early-stage mycosis fungoides: a randomized clinical trial","volume":"155","author":"Vieyra-Garcia","year":"2019","journal-title":"JAMA Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1200\/JCO.2001.19.9.2456","article-title":"Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results","volume":"19","author":"Duvic","year":"2001","journal-title":"J Clin Oncol."},{"key":"B22","first-page":"581","article-title":"Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma","volume":"137","author":"Duvic","year":"2001","journal-title":"Arch Dermatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1182\/blood.V92.10.3578","article-title":"Prospective randomized multicenter clinical trial on the use of interferon \u03b1-2a plus acitretin versus interferon \u03b1-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II","volume":"92","author":"Stadler","year":"1998","journal-title":"Blood."},{"key":"B24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1001\/jamadermatol.2018.5204","article-title":"Comparison of narrowband UV-B with Psoralen-UV-A phototherapy for patients with early-stage mycosis fungoides: a systematic review and meta-analysis","volume":"155","author":"Phan","year":"2019","journal-title":"JAMA Dermatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/ijd.14132","article-title":"Health-related quality of life in patients with cutaneous T-cell lymphoma?","volume":"57","author":"Holahan","year":"2018","journal-title":"Int J Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jamadermatol.2018.5844","article-title":"Psoralen plus UV-A therapy in the 21st century","volume":"155","author":"Guitart","year":"2019","journal-title":"JAMA Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/105294199277860","article-title":"The International conference on harmonization good clinical practice guideline","volume":"6","author":"Dixon","year":"1999","journal-title":"Qual Assur."},{"key":"B28","doi-asserted-by":"publisher","first-page":"650","DOI":"10.2471\/BLT.08.050955","article-title":"Public health classics","volume":"86","author":"Williams","year":"2008","journal-title":"Bulletin of the World Health Oranization"},{"key":"B29","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jaad.2014.03.039","article-title":"Quality of life in persons living with psoriasis patients","author":"Mart","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/bjd.17243","article-title":"Measurement properties of three assessments of burden used in atopic dermatitis in adults","volume":"180","author":"Patel","year":"2019","journal-title":"Br J Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0190-9622(03)01475-0","article-title":"Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial","volume":"49","author":"Heald","year":"2003","journal-title":"J Am Acad Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/bjd.18435","article-title":"DLQI-R scoring improves the discriminatory power of Dermatology life quality index in psoriasis, pemphigus and morphea patients","volume":"182","author":"Rencz","year":"2019","journal-title":"Br J Dermatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"291586","DOI":"10.1155\/2014\/291586","article-title":"Effect of oral puvasol on the quality of life in indian patients having chronic plaque psoriasis","volume":"2014","author":"Gahalaut","year":"2014","journal-title":"Dermatol Res Pract."},{"key":"B34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaad.2016.03.026","article-title":"Clinical meaningfulness of complete skin clearance in psoriasis","volume":"75","author":"Strober","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/bjd.18361","article-title":"Complete skin clearance and Psoriasis area and severity index response rates in clinical practice: predictors, health-related quality of life improvements and implications for treatment goals","volume":"182","author":"Norlin","year":"2020","journal-title":"Br J Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/phpp.12479","article-title":"Narrowband ultraviolet B phototherapy improves quality of life of psoriasis and atopic dermatitis patients up to 3 months: results from an observational multicenter study","volume":"35","author":"V\u00e4kev\u00e4","year":"2019","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"B37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jaad.2016.04.054","article-title":"Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): a phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)","volume":"75","author":"Simpson","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jaad.2015.10.043","article-title":"Patient burden of moderate to severe atopic dermatitis (AD): insights from a phase 2b clinical trial of dupilumab in adults","volume":"74","author":"Simpson","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand."},{"key":"B40","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2340\/00015555-1638","article-title":"Anxiety, depression, quality of life and patient satisfaction in Acne patients treated with oral Isotretinoin","volume":"93","author":"Marron","year":"2013","journal-title":"Acta Derm Venereol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jamadermatol.2019.0759","article-title":"Depression and anxiety in adults with Hidradenitis suppurativa a systematic review and meta-analysis","volume":"155","author":"Shyu","year":"2019","journal-title":"JAMA Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/jdv.15634","article-title":"Atopic eczema: burden of disease and individual suffering \u2013 results from a large EU study in adults","volume":"33","author":"Ring","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/bjd.17683","article-title":"Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U. S. adults","volume":"181","author":"Silverberg","year":"2019","journal-title":"Br J Dermatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1111\/jdv.14449","article-title":"The association between the clinical diversity of psoriasis and depressive symptoms: the HUNT study, Norway","volume":"31","author":"Modalsli","year":"2017","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jpsychores.2019.03.018","article-title":"Screening for depression in acute coronary syndrome patients: a comparison of patient health questionnaire-9 versus hospital anxiety and depression scale-depression","volume":"121","author":"Yuan","year":"2019","journal-title":"J Psychosom Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.12740\/PP\/94469","article-title":"Prevalence of pain in patients with multiple sclerosis and its association with anxiety, depressive symptoms and quality of life","volume":"53","author":"\u0141abuz-Roszak","year":"2019","journal-title":"Psychiatr Pol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11136-018-2024-z","article-title":"Anxiety, depression and quality of life in chronic obstructive pulmonary disease patients and caregivers: an actor\u2013partner interdependence model analysis","volume":"28","author":"Ivziku","year":"2019","journal-title":"Qual Life Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00296-017-3819-x","article-title":"Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus","volume":"37","author":"Almeida","year":"2017","journal-title":"Rheumatol Int."},{"key":"B49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/1756-185X.12456","article-title":"Prevalence of depressive and anxiety disorders and validation of the Hospital anxiety and depression scale as a screening tool in axial spondyloarthritis patients","volume":"20","author":"Chan","year":"2017","journal-title":"Int J Rheum Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e12901","DOI":"10.1111\/ecc.12901","article-title":"Fear of cancer progression in patients with stage IA malignant melanoma","volume":"27","author":"Wagner","year":"2018","journal-title":"Eur J Cancer Care."},{"key":"B51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/bs9070078","article-title":"Behavioral sciences Anxiety and depression in Adolescents with severe asthma and in their parents : preliminary results after 1 year of treatment","volume":"9","author":"Licari","year":"2019","journal-title":"Behav Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijcard.2017.07.065","article-title":"Screening of depression in cardiology: a study on 617 cardiovascular patients","volume":"245","author":"Tesio","year":"2017","journal-title":"Int J Cardiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jpsychores.2012.04.015","article-title":"Screening for anxiety and depression in dialysis patients: comparison of the hospital anxiety and depression scale and the beck depression inventory","volume":"73","author":"Preljevic","year":"2012","journal-title":"J Psychosom Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/jid.2015.56","article-title":"Skin under the (Spot)-light: Cross-talk with the central hypothalamic-pituitary-adrenal (HPA) axis","volume":"135","author":"Jozic","year":"2015","journal-title":"J Invest Dermatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.cell.2014.04.032","article-title":"Skin \u03b2-endorphin mediates addiction to UV light","volume":"157","author":"Fell","year":"2014","journal-title":"Cell."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.cell.2014.06.009","article-title":"Shedding \u201cuV\u201d light on endogenous opioid dependence","volume":"157","author":"Tejeda","year":"2014","journal-title":"Cell."},{"key":"B57","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/exd.13021","article-title":"Opioids and skin homeostasis, regeneration and ageing \u2013 what's the evidence?","volume":"25","author":"Bigliardi","year":"2016","journal-title":"Exp Dermatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1039\/C6PP00337K","article-title":"Serum endocannabinoids and N-acyl ethanolamines and the influence of simulated solar UVR exposure in humans in vivo","volume":"16","author":"Felton","year":"2017","journal-title":"Photochem Photobiol Sci."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00330\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T04:30:47Z","timestamp":1596601847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00330\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":58,"alternative-id":["10.3389\/fmed.2020.00330"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.00330","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]},"article-number":"330"}}